2014 was a great year for Trusted Health Group (THG). They started in February by acquiring Innovite Health and rang out the old year with some more exciting news – an announcement that they would be amalgamating the existing product, sales and marketing operations of Afinity Life Sciences Inc., based in Edmonton.
Afinity (www.afinity.ca) researches, develops and brings to market natural health-based therapeutics – was founded in 2012 by Dr. Jacqueline J. Shan, Ph.D., D.Sc., who is the creator of the highly acclaimed and market-leading COLD-FX®, which became the best-selling cold and flu product ever sold in Canada, exceeding the sale of all other OTC cold and flu remedies (natural or drug) in the store and bringing that company to a market capitalization of about $500 million, an exceptional breakthrough by Canadian standards.
Dr. Shan is now the Chief Science Officer at THG, overseeing all product decisions for all brands, and will be working closely with Dr. Lee Know and others to advance THG’s health mission. The Afinity Brand is already available at a number of large chains including Loblaws, London Drugs, and Rexall.
Innovite Brand is now squarely positioned as THG’s superior, high end product line focused within independent Health Food stores and independent pharmacy retailers, and the professional, hospital, and health clinic channel.
The agreement maintains a separate, stand-alone research center based in Edmonton, Alberta. It is the aim of this institution to be a focal point for research and learning for all of Canada, driving better science and understanding of health conditions and the use of natural health products to address those conditions, and also to raise the stature and credibility of natural health products by health professionals and the general public. Dr. Shan will lead the development of this independent institution.
Dr. Shan is also nominated to join the THG Board of Directors, where she will be involved in all activities of the Corporation going forward.
